130 For example, a popular dual agonist, tirzepatide (brand name Mounjaro), activates both GLP-1 and GIPR
When NNMT is blocked, NAD+ is preserved, which fuels sirtuin activity and improves mitochondrial function
Weaknesses : Limited Direct Evidence for T1D : While the use of GLP-1 receptor agonists in T2D is well supported, there is a paucity of large-scale, long-term clinical trials examining their use as adjuncts to insulin in T1D, particularly for those with overweight or obesity
Although initial studies suggested that GSH depletion was only a byproduct of oxidative stress generated during cell death, recent discoveries suggest that GSH depletion and post-translational modifications of proteins through glutathionylation are critical regulators of apoptosis
Curr Drug Discov Technol 18:405413